patent/BR-112013031510-A2

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-112013031510-A2

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5355 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0463 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-10
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5355 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
filingDate	2012-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61b7fd4bbec84335debed33adb09590f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea1add34d37a5f60ef98e3fa58d721db http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c524fc5ee0715def6de134ac4f9d308 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71a09f7b6ded4abf20af4878000b8829 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1587176c842f346fcdb10c856e049df http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bbac162bb593d4df4c38029729b259d1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_520f33558afc03a605e7c82123805a40
publicationDate	2016-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	BR-112013031510-A2
titleOfInvention	[1,3] oxazines
abstract	patent abstract: "[1,3] oxazine". The present invention relates to compounds of formula I having bace1 and / or bace2 inhibitory activity, manufacture thereof, pharmaceutical compositions containing them and use as therapeutically active substances. The active compounds of the present invention are useful in the therapeutic and / or prophylactic treatment of, for example, Alzheimer's disease and type 2 diabetes. The invention also provides a radiolabelled derivative thereof.
priorityDate	2011-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421208039 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12313776 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15560522 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421208097

Total number of triples: 29.